Lilly Unveils Blueprint for Speeding Innovative Medicines t...(tments and cures for deadly diseases and...),Health

Date:9/14/2009

tments and cures for deadly diseases, and to improve on inadequate options for many diseases - has never been greater. With the largest early- to mid-stage pipeline in our history, the opportunities for Lilly have also never been greater. The test for our company is to bring those medicines to patients more efficiently and provide demonstrable value.

"While our structure and approach served us well in the past, we must take measures now that will make us leaner, more focused, more customer-oriented, and more competitive," said Lechleiter. "The changes we're making will simplify our organization, clarify accountability and authority, and speed decision making."

Lechleiter said the move to business units combined with a lower cost structure will allow Lilly to deliver valued innovation quicker and at less cost and thus provide greater value to customers. The realigned organization will focus on speeding delivery of innovative medicines to market; establishing leadership positions in cancer and diabetes therapies; realizing the opportunity for growth in emerging markets and the company's animal health business; and introducing new products in the company's largest base, the established markets.

Activities are currently under way to put the new operating model in place, with the goal of transitioning to the new organization on January 1, 2010. On December 10, 2009, at the company's annual investment community day in New York City, company leaders will present additional details of the changes announced today.

"These changes will challenge us and require new ways of thinking and acting," concluded Lechleiter. "Under this new operating model, Lilly has the opportunity not only to better navigate this uncertain, challenging time, but to emerge with renewed strength and focus."

In connection with today's announcement, the company confirmed its previous 2009 earnings per share g
'/>"/>

SOURCE Eli Lilly and Company Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Lilly Names New Business Leaders
2. Chicago Bears Quarterback Jay Cutler, Eli Lilly and Company and the American Diabetes Association Team Up to Fund Diabetes Camp Scholarships Through "Touchdowns for Diabetes"
3. Lilly Named Best Company for Blacks in Technology
4. Lilly Reports on Outcome of Phase III Study of Arzoxifene
5. U.S. District Court Rules Against Lilly Regarding Gemzar Patent
6. Eli Lilly-Children International Launches Teen Campaign to Reduce TB Cases in India
7. Lilly Broadens Income Eligibility for Patient Assistance Programs
8. Lilly Announces Continued Commitment to Transparency with Faculty Registry
9. Lilly to Unveil More Than 30 Studies at Premier Lung Cancer Meeting
10. Lilly Receives Award From National Medical Association
11. FDA Approves Expanded Use of Lillys FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis